JM
Jay Matushak
Chief Financial Officer

Jay Matushak insider trades: NeueHealth (NEUE) stock sales

Chief Financial Officer, NeueHealth Last trade May 12, 2025 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2023
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jay reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 12, 2025NEUE↓ Sell$3K
Mar 14, 2025NEUE↓ Sell$39K
Mar 12, 2025NEUE↓ Sell$17K
Mar 10, 2025NEUE↓ Sell$15K
Jan 6, 2025NEUE↓ Sell$36K
Oct 7, 2024NEUE↓ Sell$451
May 10, 2024NEUE↓ Sell$2K
Mar 18, 2024NEUE↓ Sell$8K
Mar 15, 2024NEUE↓ Sell$3K
Mar 13, 2024NEUE↓ Sell$4K
Mar 8, 2024NEUE↓ Sell$9K
Oct 5, 2023BHG↓ Sell$497

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jay Matushak's insider trades

Jay Matushak is Chief Financial Officer at NeueHealth (NEUE). Since Oct 5, 2023, Jay has reported no open-market purchases and 12 sales worth $137K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (10 filings), shares returned to the company (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEUE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.